Testing effectiveness (Phase 2)Study completedNCT00788775
What this trial is testing
Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Who this might be right for
Mucosal Lentiginous MelanomaAcral MelanomaMelanoma
Dana-Farber Cancer Institute 20